Kalorama Information
The independent voice, quality research, and innovative approach to the analysis and presentation of market intelligence have made Kalorama a premier source of information for top decision makers.
Kalorama Information studies are based on independent primary research conducted by analysts with years of experience in the industry, and include critical analyses and independent perspectives. Researchers build their market analysis independently from published databases, validating data with inside industry contacts and extensive secondary research. Extensive interviewing of industry executives, clinical practitioners, government policy makers, and respected consultants form the basis of every Kalorama study. Secondary sources, such as regulatory filings, company literature, press reports, and commercial databases, are used to validate market assumptions and detail industry events.
Kalorama provides several critical research products.
The Market Profiles are in-depth analyses of specific markets. Generally several hundred pages in length, Market Profiles provide market size; growth rates; market share and profiles of market leaders, including technologies, products, and business strategies; and analysis of major clinical, demographic, and regulatory trends.
750 Reports from Kalorama Information
-
IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests
... glucose monitoring activities will account for approximately 76% of testing volume and about $20 billion of product sales. Excluding blood glucose tests, global IVD procedural volume is forecast to rise 4.0% annually to 28.8 billion ... Read More
-
Vaccines 2020: World Market Analysis, Players, Trends
... developmental vaccines for diseases that are already vaccine-preventable, with a discussion of selected emerging vaccines for diseases that are not currently vaccine-preventable, such as addiction and malaria. The report also discusses trends and looks at ... Read More
-
The Worldwide Market for In Vitro Diagnostics, 13th Edition
... COVID Testing – Immunoassays and Molecular Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, PGx, Tissue Typing, Prenatal) Clinical Chemistry and “Core Lab” Markets Point-of-Care Testing (POC) (Professional and Self-Testing) Glucose Testing Substance ... Read More
-
Molecular Diagnostics Markets in The COVID-19 Era
... the growth of the worldwide market for molecular diagnostics in all major segments, and does so in this edition as a pandemic has reached developed markets including the United States. 2020 was set to be ... Read More
-
Emerging Infectious Disease Diagnostics: Markets and Trends
... of preparation for a viral epidemic. He predicted that it would be “microbes, not missiles” that would cause significant harm to humans. Events in recent years have proven him right. Outbreaks of infections such as ... Read More
-
Hematology and Coagulation Markets (Lab-based and Decentralized Markets)
... and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, ... Read More
-
Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
... countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for ... Read More
-
Outsourcing in Drug Discovery, 9th Edition
... effective cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug discovery process, the business of contract drug discovery ... Read More
-
Cell Therapy and Gene Therapy Markets
... of products. Cell and gene therapy products are transforming the treatment of cancers and genetic diseases, as well as expanding into other areas of medicine including autoimmune diseases, cardiovascular diseases, musculoskeletal disease, dermatological diseases, and ... Read More
-
Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline
... the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine development as it stands ... Read More
-
Artificial Intelligence Markets in IVD
... to market and many more are in development. In recent years, diagnostics companies – in collaboration with AI companies – have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis ... Read More
-
Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas
... during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: ... Read More
-
The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)
... of a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 ... Read More
-
The Market and Future Potential for Molecular Point of Care
... turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and ... Read More
-
Molecular Cancer Diagnostics Market
... of leukemia and lymphoma. Later, the emergence of user-friendly molecular methods such as PCR has opened up practical applications that helped multiple approaches for cancer diagnosis and treatments. DNA sequencing is increasingly employed in cancer ... Read More
-
Worldwide Wound Care Market Summary
... Information's report, Worldwide Wound Care Market Summary, identifies market opportunity for major sectors of this important market. A particular focus is given to biotechnology used in wound care, including advanced biodressings and negative pressure wound ... Read More
-
Clinical Laboratory Services Market, 5th Edition
... diagnosing patients, clinical lab testing may be performed to evaluate disease progression, to monitor drug treatment and conditions, and to determine individual therapy. Kalorama’s Clinical Laboratory Services Market, 5th Edition, examines the world and regional ... Read More
-
NASH Drug Pipeline and Market Overview
... scarring of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the ... Read More
-
CAR-T Cell Therapy Market Review
... meaning that each patient receives T cells that are geared specifically toward his or her cancer diagnosis. T-cell therapy works by removing existing T cells from a patient and having them grown and modified in ... Read More
-
Exome Sequencing Market
... is a widely used NGS technique that sequences all the exons in a genome. Rather than sequencing the entire human genome, only pieces of an individual's DNA that provide instructions for making proteins are sequenced. ... Read More
-
Blockchain Technologies in Healthcare
... that it has three components: a widely distributed network a shared ledger with validated access identities digital transactions Blockchain technology is emerging in many other industries but it has some unique challenges in healthcare. Blockchain ... Read More
-
Current IVD Market Trends
... are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose ... Read More
-
The Global Market for Medical Devices, 10th Edition (45 Specific Device Markets and 50 Country Markets Forecasted to 2024)
... device market and opportunity for medical device manufacturers, competitors, and investors. The report examines the companies in the market, the types of devices sold across the global market, and the country markets they are sold ... Read More
-
The World Market for HbA1c Tests
... is being spent annually on HbA1c testing, for both professional and self-testing. Over a dozen companies produce analyzers, reagents, workstations, and point-of-care (POC) devices that run HbA1c tests. A major contributing factor to growth is ... Read More
-
IVD Test Procedure Volumes, 2019-2024
... marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2019-2024 saves time with calculations and estimates of the both the existing number of procedures for scores of diagnostic tests, and the future potential. In ... Read More
View a sample report from this publisher.
Download Sample ReportResearch Assistance
Join Alert Me Now!
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook